| scholarly article | Q13442814 |
| P50 | author | Juan-Manuel Anaya | Q37366533 |
| Adriana Rojas-Villarraga | Q54536996 | ||
| Juan Camilo Sarmiento-Monroy | Q56452414 | ||
| Juan Sebastián Espinosa-Serna | Q56452415 | ||
| Jenny Amaya-Amaya | Q60568054 | ||
| P2093 | author name string | Catalina Herrera-Díaz | |
| P2860 | cites work | [Ventricular diastolic dysfunction in rheumatoid arthritis] | Q82786404 |
| Factors associated with hyperhomocysteinaemia in Mexican patients with rheumatoid arthritis | Q83205796 | ||
| The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration | Q27860647 | ||
| Relative risk of cardiovascular events in patients with rheumatoid arthritis | Q28192599 | ||
| Differences in clinical status measures in different ethnic/racial groups with early rheumatoid arthritis: implications for interpretation of clinical trial data. | Q31101210 | ||
| EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis | Q33505914 | ||
| Inflammation and microvascular and macrovascular endothelial dysfunction in rheumatoid arthritis: effect of treatment | Q33531382 | ||
| Rheumatoid factor, chronic arthritis and mortality | Q33578403 | ||
| A1298C polymorphism in the MTHFR gene predisposes to cardiovascular risk in rheumatoid arthritis. | Q33923484 | ||
| Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness | Q34153114 | ||
| Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis | Q34182804 | ||
| Antiphospholipid syndrome, antiphospholipid antibodies, and atherosclerosis | Q34271982 | ||
| Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis | Q34283776 | ||
| The global burden of chronic diseases: overcoming impediments to prevention and control | Q34323994 | ||
| Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis | Q34401259 | ||
| Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis | Q34515105 | ||
| Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? | Q34601733 | ||
| A genomewide admixture map for Latino populations | Q34628377 | ||
| Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies | Q34889152 | ||
| Dyslipidaemia in rheumatological autoimmune diseases | Q35029916 | ||
| CCR5Δ32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study | Q35617726 | ||
| Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study | Q35638342 | ||
| Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis | Q35638369 | ||
| Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review. | Q35667122 | ||
| A genomewide admixture mapping panel for Hispanic/Latino populations. | Q35788553 | ||
| Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study | Q35815364 | ||
| Endothelial dysfunction in rheumatoid arthritis: influence of HLA-DRB1 alleles | Q35832305 | ||
| Coronary and valvular syndromes and antiphospholipid antibodies | Q35928744 | ||
| Rheumatoid arthritis and cardiovascular disease: the role of systemic inflammation and evolving strategies of prevention | Q36101597 | ||
| Vascular comorbidity in rheumatoid arthritis: potential mechanisms and solutions | Q36101622 | ||
| Accelerated atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus | Q36166439 | ||
| Accelerated atherosclerosis in autoimmune rheumatic diseases | Q36318870 | ||
| Cardiovascular disease in rheumatoid arthritis | Q36438681 | ||
| The heart and cardiovascular manifestations in rheumatoid arthritis | Q36596365 | ||
| Impact of age on clinical manifestations and outcome in Puerto Ricans with rheumatoid arthritis | Q36600485 | ||
| Vascular complications of scleroderma | Q36940162 | ||
| Hypertension in rheumatoid arthritis. | Q37158219 | ||
| The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus | Q37206876 | ||
| Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus | Q37331971 | ||
| Genetic epidemiology of rheumatoid arthritis: what to expect from Latin America? | Q44948449 | ||
| Rheumatoid arthritis in African Colombians from Quibdo | Q46215643 | ||
| Health status disparities in ethnic minority patients with rheumatoid arthritis: a cross-sectional study | Q46304908 | ||
| Early rheumatoid arthritis in Latin America: low socioeconomic status related to high disease activity at baseline | Q46322834 | ||
| Analysis of the ulsefulnes of contrast echocardiography and nuclear medicine in cardiovascular affection due to autoimmune diseases | Q46503806 | ||
| Auto-antibodies do not influence development of atherosclerotic plaques in rheumatoid arthritis. | Q46610997 | ||
| Prevalence and factors associated with metabolic syndrome in patients with rheumatoid arthritis and systemic lupus erythematosus | Q46662161 | ||
| Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis. | Q46852341 | ||
| Single measurements of C-reactive protein and disease activity scores are not predictors of carotid atherosclerosis in rheumatoid arthritis patients. | Q47779221 | ||
| Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. | Q50701881 | ||
| Metabolic syndrome prevalence is increased in rheumatoid arthritis patients and is associated with disease activity. | Q50957777 | ||
| Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease. | Q51024206 | ||
| Cardiovascular disease is associated with extra-articular manifestations in patients with rheumatoid arthritis. | Q51773790 | ||
| Common carotid intima-media thickness and von Willebrand factor serum levels in rheumatoid arthritis female patients without cardiovascular risk factors. | Q51801169 | ||
| Metabolic syndrome in rheumatological diseases. | Q37377015 | ||
| Cardiovascular disease in rheumatoid arthritis: a step forward | Q37694260 | ||
| Cardiac involvement in systemic rheumatic diseases: An update | Q37778555 | ||
| Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives | Q37812524 | ||
| Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment | Q37833721 | ||
| Cardiovascular disease risk in rheumatoid arthritis: progress, debate, and opportunity | Q37859676 | ||
| The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk | Q37871668 | ||
| Rheumatoid arthritis and metabolic syndrome. | Q37882443 | ||
| Vascular function and morphology in rheumatoid arthritis: a systematic review | Q37934239 | ||
| Serum oxidized low-density lipoproteins in rheumatoid arthritis | Q38518891 | ||
| CARMELA: assessment of cardiovascular risk in seven Latin American cities | Q39828407 | ||
| Polymorphisms of the endothelin-1 gene associate with hypertension in patients with rheumatoid arthritis | Q40065488 | ||
| Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events. | Q40461525 | ||
| HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis | Q42610707 | ||
| Meta-analysis of HLA-DRB1 polymorphism in Latin American patients with rheumatoid arthritis | Q42622247 | ||
| Risk factors associated with different stages of atherosclerosis in Colombian patients with rheumatoid arthritis. | Q42651242 | ||
| Impact of cardiovascular illness on hospitalization costs in patients with rheumatoid arthritis | Q43498266 | ||
| Disease activity as a risk factor for myocardial infarction in rheumatoid arthritis | Q43836845 | ||
| Epidemiology of the rheumatic diseases in Mexico. A study of 5 regions based on the COPCORD methodology | Q44058082 | ||
| Cardiovascular risk factors in Chilean patients with rheumatoid arthritis. | Q44103547 | ||
| Glucocorticoids and insulin sensitivity in rheumatoid arthritis | Q44881615 | ||
| Rheumatoid arthritis | Q56656479 | ||
| Cardiovascular risk factors in primary Sjögren's syndrome: a case-control study in 624 patients | Q56907410 | ||
| NFKB1-94ATTG ins/del polymorphism (rs28362491) is associated with cardiovascular disease in patients with rheumatoid arthritis | Q57307062 | ||
| TNFA −308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis | Q57307074 | ||
| Carotid Intima-Media Thickness Predicts the Development of Cardiovascular Events in Patients with Rheumatoid Arthritis | Q57307089 | ||
| Anticorpos contra LDL-ox e síndrome coronariana aguda | Q58369072 | ||
| Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: Effects of tumor necrosis factor-α blockade | Q58418512 | ||
| Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis | Q59394301 | ||
| HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis | Q61971712 | ||
| Ventricular function abnormalities in active rheumatoid arthritis: a Doppler echocardiographic study | Q73559007 | ||
| Prevalence of rheumatoid arthritis in Tucumán, Argentina | Q74299748 | ||
| Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis | Q79698753 | ||
| Cardiovascular diseases in Latin America and the Caribbean | Q80141255 | ||
| Antiphospholipid antibodies in acute coronary syndrome | Q80434476 | ||
| Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis | Q80808131 | ||
| Cardiovascular death in rheumatoid arthritis: a population-based study | Q81484761 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| cardiovascular disease | Q389735 | ||
| systematic review | Q1504425 | ||
| P304 | page(s) | 371909 | |
| P577 | publication date | 2012-10-31 | |
| P1433 | published in | Arthritis | Q26853914 |
| P1476 | title | Cardiovascular disease in rheumatoid arthritis: a systematic literature review in latin america | |
| P478 | volume | 2012 |
| Q47988471 | Assessment of six cardiovascular risk calculators in Mexican mestizo patients with rheumatoid arthritis according to the EULAR 2015/2016 recommendations for cardiovascular risk management. |
| Q37330468 | Cardiovascular disease in latin american patients with systemic lupus erythematosus: a cross-sectional study and a systematic review. |
| Q34081242 | Cardiovascular involvement in autoimmune diseases |
| Q90673384 | Cardiovascular risk factors' behavior during the early stages of the disease, in Hispanic rheumatoid arthritis patients: a cohort study |
| Q27331466 | Cholesterol-induced non-alcoholic fatty liver disease and atherosclerosis aggravated by systemic inflammation |
| Q89278102 | Comparison of statin eligibility according to the Adult Treatment Panel III, ACC/AHA blood cholesterol guideline, and presence of carotid plaque by ultrasound in Mexican mestizo patients with rheumatoid arthritis |
| Q35671305 | GDF15(MIC1) H6D Polymorphism Does Not Influence Cardiovascular Disease in a Latin American Population with Rheumatoid Arthritis |
| Q35681167 | Hyperlipidemia in rheumatoid arthritis patients in Saudi Arabia. Correlation with C-reactive protein levels and disease activity |
| Q34157718 | Longterm blood pressure variability in patients with rheumatoid arthritis and its effect on cardiovascular events and all-cause mortality in RA: a population-based comparative cohort study |
| Q92841540 | Morbidity and mortality in patients with rheumatoid arthritis compared with an age- and sex-matched control population: A nationwide register study |
| Q38098935 | Novel risk factors for cardiovascular disease in rheumatoid arthritis |
| Q38691780 | Prevalence of comorbidities in Mexican mestizo patients with rheumatoid arthritis |
| Q38858035 | Prevalence of metabolic syndrome in patients with rheumatoid arthritis in Morocco: a cross-sectional study of 179 cases |
| Q36027291 | Therapeutic potential of folic acid supplementation for cardiovascular disease prevention through homocysteine lowering and blockade in rheumatoid arthritis patients. |
Search more.